| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | WO1998003502A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 01/29/1998 | WO1998003496A1 Furan nitrone compounds |
| 01/29/1998 | WO1998003194A2 Substance p treatment for immunostimulation |
| 01/29/1998 | WO1998003189A1 Use of conantokins |
| 01/29/1998 | WO1998003162A1 Medicinal compositions |
| 01/29/1998 | DE19630230A1 Herstellung immunstimulierender Mittel auf Basis von Propionibakterien Preparation of immunostimulating agents based on propionibacteria |
| 01/29/1998 | DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments |
| 01/29/1998 | CA2261885A1 Substance p treatment for immunostimulation |
| 01/29/1998 | CA2261570A1 Use of conantokins |
| 01/29/1998 | CA2261291A1 Pasteurization of immunoglobulin solutions |
| 01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | CA2260825A1 Furan nitrone compounds |
| 01/29/1998 | CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | CA2258872A1 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 01/29/1998 | CA2256736A1 New triazolopurines, method of preparing them and their use as drugs |
| 01/29/1998 | CA2232142A1 Cd6 ligand |
| 01/28/1998 | EP0820772A1 Immunomodulating medicinal agent |
| 01/28/1998 | EP0820472A1 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 01/28/1998 | EP0820471A1 Antibodies against heart muscle actin |
| 01/28/1998 | EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 01/28/1998 | EP0820461A1 Chemical compounds |
| 01/28/1998 | EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 01/28/1998 | EP0820433A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 01/28/1998 | EP0820309A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 01/28/1998 | EP0820304A1 Chlamydia vaccines |
| 01/28/1998 | EP0820284A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 01/28/1998 | EP0820283A1 Lactacystin analogs |
| 01/28/1998 | EP0752886B1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/28/1998 | CN1171736A Matrix type patch preparations |
| 01/27/1998 | US5712303 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
| 01/27/1998 | US5712298 Bronchodilator agents, treatment of asthma, antiinflammatory, treatment of skin disorders |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712286 Modulators of cytokine synthesis, antirheumatic agents |
| 01/27/1998 | US5712155 DNA encoding tumor necrosis factor-α and -β receptors |
| 01/27/1998 | US5712129 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 01/27/1998 | US5712115 Polynucleotide encoding polypeptide with amino acid sequences |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/22/1998 | WO1998002529A1 Highly productive packaging lines |
| 01/22/1998 | WO1998002459A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | WO1998002452A2 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | WO1998002151A2 Chemokine receptor antagonists and methods of use therefor |
| 01/22/1998 | WO1998002038A1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 01/22/1998 | WO1997035591A3 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/22/1998 | CA2262814A1 Highly productive packaging lines_ |
| 01/22/1998 | CA2260738A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | CA2259966A1 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | CA2259927A1 Chemokine receptor antagonists and methods of use therefor |
| 01/21/1998 | EP0819763A1 Engineered acarid allergen and process for producing the same |
| 01/21/1998 | EP0819681A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use |
| 01/21/1998 | EP0819177A1 Expression library immunization |
| 01/21/1998 | EP0819171A1 Antibodies for the detection of hla-g |
| 01/21/1998 | EP0819168A1 Human tumor necrosis factor receptor |
| 01/21/1998 | EP0819130A1 Ascomycins |
| 01/21/1998 | EP0819123A1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/21/1998 | EP0819122A1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 01/21/1998 | EP0701443B1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 01/21/1998 | EP0650363B1 Antiviral combinations |
| 01/21/1998 | EP0594636B1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171118A Fibronectin adhesion inhibitors |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171052A Vaccine adjuvants |
| 01/21/1998 | CN1170593A Linghuang oral liquid made from Gaboderma lucidum and scutellaria root |
| 01/21/1998 | CN1037104C Novel cyclosporins |
| 01/20/1998 | US5710262 Nucleic acid encoding HB15 polypeptides |
| 01/20/1998 | US5710257 Method of causing selective immunosuppression using HL-60-related lectins |
| 01/20/1998 | US5710169 Therapeutic heterocycles |
| 01/20/1998 | US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases |
| 01/20/1998 | US5710158 Inhibitors of protein tyrosine kinase and epidermal growth factor |
| 01/20/1998 | US5710142 Vitamin D analogues |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/20/1998 | US5709853 Method of treatment of atopic disease |
| 01/19/1998 | CA2210613A1 N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001449A1 Novel compounds |
| 01/15/1998 | WO1998001150A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | CA2260295A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2260057A1 Novel compounds |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2258697A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/14/1998 | EP0818454A1 Benzimidazole derivatives with antihistaminic activity |
| 01/14/1998 | EP0818442A2 Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| 01/14/1998 | EP0818202A1 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid |
| 01/14/1998 | EP0818201A1 Use of a polysaccharide to stimulate immune defenses |
| 01/14/1998 | EP0817860A1 Pseudotyped retroviral particles |
| 01/14/1998 | EP0817855A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors |
| 01/14/1998 | EP0817847A1 Il-17 receptor |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817786A1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 01/14/1998 | EP0817770A1 Nonpeptides as tachykinin antagonists |
| 01/14/1998 | EP0817650A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817642A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
| 01/14/1998 | EP0817637A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |